Polianta Ltd’s Surgery Partners SGRY Stock Holding History

Polianta Ltd’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,900	Closed	-$546K	–	89
2022 Q2	$546K	Buy	+18,900	New	+$826K	0.47%	59

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Polianta Ltd's SGRY Position: Q3 2022 in Review

Polianta Ltd sold out of Surgery Partners (SGRY) in Q3 2022, closing a stake of 18,900 shares — an estimated $546K sold.

Polianta Ltd first reported a position in SGRY in Q2 2022 and held it in 1 quarter. The position peaked at $546K in Q2 2022. 138 funds tracked by Wall St. Rank hold SGRY as of Q3 2022.

Polianta Ltd reported no remaining Surgery Partners position as of Q3 2022 after selling out during the quarter.
Polianta Ltd sold 18,900 Surgery Partners shares in Q3 2022, an estimated $546K.
Polianta Ltd first reported a position in Surgery Partners in Q2 2022 and held it in 1 quarter.
Polianta Ltd's Surgery Partners position peaked at $546K in Q2 2022.
138 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2022.

Based on Polianta Ltd's 13F filing for Q3 2022, filed 18 Oct 2022.